Artobend (autologous human chondrocytes in vitro expanded)
- Region
- 🇪🇺 EU
- Active substance
- autologous human chondrocytes in vitro expanded
- Company
- TETEC Tissue Engineering Technologies AG
- Status
- Application withdrawn
- Therapeutic area
- Fractures, Cartilage
- Application
- EMEA/H/C/004598
- ATC
- M09AX02
- Official record
- www.ema.europa.eu
Indication
Repair of cartilage defects of the knee joint.
Regulatory milestones
No milestones recorded in the last year.
Follow Artobend
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.